Viewing Study NCT01211002


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2025-12-26 @ 3:00 AM
Study NCT ID: NCT01211002
Status: UNKNOWN
Last Update Posted: 2010-09-29
First Post: 2010-09-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC)
Sponsor: Simcere Pharmaceutical Co., Ltd
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-10
Start Date Type: None
Primary Completion Date: 2011-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2012-12
Completion Date Type: ESTIMATED
First Submit Date: 2010-09-27
First Submit QC Date: None
Study First Post Date: 2010-09-29
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2010-09-28
Last Update Post Date: 2010-09-29
Last Update Post Date Type: ESTIMATED